PRESS RELEASE published on 04/16/2026 at 18:00, 3 months 22 days ago Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC Oxurion NV received a transparency notification from Atlas Special Opportunities II, LLC regarding shareholding crossing threshold under Belgian Transparency legislation Transparency Notification Shareholding Oxurion NV Belgian Legislation Atlas Special Opportunities II LLC
BRIEF published on 04/07/2026 at 18:05, 4 months 1 day ago Oxurion postpones its Annual General Meeting Pharmaceutical Digital Assets General Assembly Report Oxurion
BRIEF published on 04/07/2026 at 18:05, 4 months 1 day ago Oxurion Postpones Annual Shareholders Meeting Financial Calendar Shareholders Meeting Investment Risks Oxurion Pharmaceutical Outsourcing
PRESS RELEASE published on 04/07/2026 at 18:00, 4 months 1 day ago Postponement Annual Shareholders Meeting Oxurion NV postpones Annual Shareholders Meeting to June 1st, 2026 due to pending annual accounts. The pharmaceutical outsourcing company specializes in acquiring European subcontractors. Forward-looking statements in press release Forward-looking Statements Postponement Oxurion NV Pharmaceutical Outsourcing European Subcontractors
BRIEF published on 03/19/2026 at 18:35, 4 months 20 days ago Oxurion plans to acquire an international CRO Growth Strategy Acquisition Clinical Development Oxurion International CRO
BRIEF published on 03/19/2026 at 18:35, 4 months 20 days ago Oxurion Announces Intent to Acquire International CRO Acquisition Clinical Research Pharmaceutical International Expansion Oxurion
PRESS RELEASE published on 03/19/2026 at 18:30, 4 months 20 days ago Oxurion signs a letter of intent for the acquisition of an international CRO Oxurion NV (Euronext Brussels: OXUR) announces the signing of a letter of intent for acquiring an international CRO, strengthening its clinical development strategy Acquisition Clinical Development Euronext Brussels CRO Oxurion NV
BRIEF published on 03/18/2026 at 18:05, 4 months 21 days ago Oxurion Acknowledges Transparency Notification from Atlas Pharmaceuticals Transparency Oxurion Belgian Legislation Atlas Investments
BRIEF published on 03/18/2026 at 18:05, 4 months 21 days ago Oxurion receives a transparency notification from Atlas Special Opportunities Pharmaceutical Financial Transparency Atlas Special Opportunities Oxurion Digital Investments
PRESS RELEASE published on 03/18/2026 at 18:00, 4 months 21 days ago Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC Oxurion NV received a transparency notification from Atlas Special Opportunities II, LLC indicating a stake increase above the threshold. Oxurion specializes in acquiring pharmaceutical subcontractors Transparency Notification Oxurion NV Belgian Transparency Legislation Atlas Special Opportunities II Pharmaceutical Subcontractors
Published on 08/07/2026 at 23:15, 20 hours 11 minutes ago Faraday Copper Reports Second Quarter 2026 Financial Results
Published on 08/07/2026 at 23:00, 20 hours 26 minutes ago Rio Grande Resources Announces up to $2,500,000 Non-Brokered Private Placement Financing
Published on 08/07/2026 at 22:30, 20 hours 56 minutes ago UraniumX Deploys $3.8 Million to Athabasca Basin Exploration
Published on 08/07/2026 at 22:15, 21 hours 11 minutes ago Noram Lithium Engages 1353656 BC Ltd. for Marketing and Management Consulting Services
Published on 08/08/2026 at 16:25, 3 hours 1 minute ago Bybit Sues North Korea and Lazarus Group, Secures Preliminary Injunction Freezing Stolen Assets in Landmark Crypto Asset Recovery Effort
Published on 08/07/2026 at 23:21, 20 hours 5 minutes ago EQS-Adhoc: Northern Data Group reports Q2 2026 including the adverse fair value movement on contingent consideration
Published on 08/07/2026 at 19:30, 23 hours 56 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 08/07/2026 at 19:15, 1 day ago ABO Energy Agrees Sale of Its Polish and Hungarian Subsidiaries
Published on 08/07/2026 at 18:10, 1 day 1 hour ago Stabilus SE: Andreas Jaeger steps down as Chief Financial Officer at his own request
Published on 08/07/2026 at 18:54, 1 day ago Covivio - Information on Treasury shares transactions between August 3rd, 2026, and August 7th, 2026
Published on 08/07/2026 at 18:40, 1 day ago Disclosure of transactions in own shares from August 3 to August 7, 2026
Published on 08/07/2026 at 17:49, 1 day 1 hour ago Crédit Agricole CIB announced the publication of the Amendment of its 2025 Universal Registration Document
Published on 08/07/2026 at 08:30, 1 day 10 hours ago Disclosure of shares outstanding and voting rights - 07.08.2026